(Q28475698)

English

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort

scientific article

In more languages

Statements

scholarly article

0 references

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort (English)

0 references

HIV transmission

0 references

Claudia Kuecherer

2

0 references

author name string

Barbara Bartmeyer

1

0 references

Claudia Houareau

3

0 references

Johanna Werning

4

0 references

Kathrin Keeren

5

0 references

Sybille Somogyi

6

0 references

Christian Kollan

7

0 references

Heiko Jessen

8

0 references

Stephan Dupke

9

0 references

Osamah Hamouda

10

0 references

language of work or name

0 references

publication date

7 October 2010

0 references

0 references

5

0 references

10

0 references

e12718

0 references

copyright license

Creative Commons Attribution 4.0 International

7 October 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

19 March 2017

HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

HIV-1 drug resistance mutations: an updated framework for the second decade of HAART

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Class-sparing regimens for initial treatment of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Update of the drug resistance mutations in HIV-1: 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Non-nucleoside reverse transcriptase inhibitors: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Epidemiology of antiretroviral drug resistance in drug-naïve persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Diversity of thymidine analogue resistance genotypes among newly diagnosed HIV-1-infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Declining trend in transmission of drug-resistant HIV-1 in Amsterdam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

HIV-1 drug resistance: can we overcome?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

29 September 2017

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

2 June 2018

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

HIV treatment decisions and transmitted drug resistance.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Long-term persistence of primary genotypic resistance after HIV-1 seroconversion.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Persistence of a sexually transmitted highly resistant HIV-1: pol quasispecies evolution over 33 months in the absence of treatment.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951346

27 November 2018

An elusive soluble suppressor

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012718

21 January 2018

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends of prevalence of primary HIV drug resistance in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update of the drug resistance mutations in HIV-1: Spring 2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949104

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0012718

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2010PLoSO...512718B

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28475698&oldid=1869955656"